Price to Sales (P/S)
since 2005
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Selected Financial Data since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Elevance Health Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Operating revenue1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Elevance Health Inc. Annual Report.
- Share Price Trend
- The share price exhibited significant volatility over the analyzed period. Initially fluctuating moderately between roughly $41 and $87 per share from 2006 to 2014, the price saw notable increases during 2014 to 2018, reaching a peak above $300 by 2019. After 2019, the share price showed a sharp rise to nearly $460 in 2022 but then experienced a dramatic and likely anomalous spike in 2023 to an extremely high level, followed by a corrected value closer to $500 in 2024 and a subsequent decline to approximately $390 by 2025. This anomaly suggests potential irregularities or data errors at that point.
- Sales Per Share Development
- Sales per share demonstrated a consistent upward trend throughout the entire period under review. Starting from approximately $68 in 2006, sales per share increased steadily year over year without any significant downturns, eventually surpassing $770 by 2025. This progression indicates strong growth in the company's revenue generation on a per share basis, suggesting enhanced operational performance or expansion of business activities over time.
- Price-to-Sales (P/S) Ratio Analysis
- The P/S ratio displayed a declining trend in the initial years, dropping from 1.14 in 2006 to a low of 0.31 around 2013, indicating the share price was moving lower relative to sales per share during this time. Following this trough, the ratio experienced moderate fluctuations but generally oscillated below 1, suggesting the market valued the company's shares at less than their sales on a per share basis for most of the period. Notably, there was an extreme and likely erroneous spike in the ratio around 2023 which corresponds with the anomalous share price seen during the same period. Aside from this outlier, the P/S ratio tended to stabilize between approximately 0.4 and 0.8 towards the later years, reflecting a relatively consistent valuation metric compared to revenue per share.
- Overall Insights
- The data reflects steady growth in underlying business performance, as evidenced by continuous sales per share expansion. However, the market valuation in terms of share price and P/S ratio showed more volatility, potentially reflecting changing investor sentiment, market conditions, or data integrity issues. The sharp irregularities in 2023 warrant further investigation for confirmation or correction. Generally, the company's sales growth outpaced share price appreciation in many years, as shown by the generally sub-1 P/S ratio, indicating a conservative valuation relative to revenue.
Comparison to Competitors
Elevance Health Inc., P/S, long-term trends, comparison to competitors
| Elevance Health Inc. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | ||||||
| Feb 21, 2024 | ||||||
| Feb 15, 2023 | ||||||
| Feb 16, 2022 | ||||||
| Feb 18, 2021 | ||||||
| Feb 19, 2020 | ||||||
| Feb 20, 2019 | ||||||
| Feb 21, 2018 | ||||||
| Feb 22, 2017 | ||||||
| Feb 19, 2016 | ||||||
| Feb 24, 2015 | ||||||
| Feb 20, 2014 | ||||||
| Feb 22, 2013 | ||||||
| Feb 22, 2012 | ||||||
| Feb 17, 2011 | ||||||
| Feb 18, 2010 | ||||||
| Feb 19, 2009 | ||||||
| Feb 21, 2008 | ||||||
| Feb 26, 2007 | ||||||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Elevance Health Inc., P/S, long-term trends, comparison to sector (health care equipment & services)
| Elevance Health Inc. | Health Care Equipment & Services | |
|---|---|---|
| Feb 20, 2025 | ||
| Feb 21, 2024 | ||
| Feb 15, 2023 | ||
| Feb 16, 2022 | ||
| Feb 18, 2021 | ||
| Feb 19, 2020 | ||
| Feb 20, 2019 | ||
| Feb 21, 2018 | ||
| Feb 22, 2017 | ||
| Feb 19, 2016 | ||
| Feb 24, 2015 | ||
| Feb 20, 2014 | ||
| Feb 22, 2013 | ||
| Feb 22, 2012 | ||
| Feb 17, 2011 | ||
| Feb 18, 2010 | ||
| Feb 19, 2009 | ||
| Feb 21, 2008 | ||
| Feb 26, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Elevance Health Inc., P/S, long-term trends, comparison to industry (health care)
| Elevance Health Inc. | Health Care | |
|---|---|---|
| Feb 20, 2025 | ||
| Feb 21, 2024 | ||
| Feb 15, 2023 | ||
| Feb 16, 2022 | ||
| Feb 18, 2021 | ||
| Feb 19, 2020 | ||
| Feb 20, 2019 | ||
| Feb 21, 2018 | ||
| Feb 22, 2017 | ||
| Feb 19, 2016 | ||
| Feb 24, 2015 | ||
| Feb 20, 2014 | ||
| Feb 22, 2013 | ||
| Feb 22, 2012 | ||
| Feb 17, 2011 | ||
| Feb 18, 2010 | ||
| Feb 19, 2009 | ||
| Feb 21, 2008 | ||
| Feb 26, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).